Toggle navigation
Home
Search
Services
Blog
Contact
About
A Multiplexed Diagnostic Immunoassay for Clostridium Difficile and Antibiotic-Associated Diarrhea
Oliver, Kerry
Radix Biosolutions, Ltd, Georgetown, TX, United States
Search 5 grants from Kerry Oliver
Search grants from Radix Biosolutions, Ltd
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Spontaneous vs. Directed Pushing: Analysis of Audiotapes of 2nd stage Labor and A
Roles of Novel Protein Complexes in Estrogen and Progesterone Receptor Signaling
Targeted Molecular Probes for Tumor Imaging
Enhancements to a human embryo, serial-section database
Modulation of P-Glycoprotein with Metallopharmaceuticals
Recently added grants:
Development of a multi-omic clinical decision platform to guide personalized therapy
Characterizing and targeting intra-tumor heterogeneity in triple negative breast cancer chemoresistance and multi-organ metastasis
Developing the evidence base for overdose policies: a multilevel analysis of NHBS
Molecular dissection of acute and chronic menthol interactions
The apical junction complex in cochlear basal cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
272201500031C-0-0-1
Application #
9148107
Study Section
Project Start
2015-09-14
Project End
2017-09-13
Budget Start
Budget End
Support Year
Fiscal Year
2015
Total Cost
Indirect Cost
Institution
Name
Radix Biosolutions, Ltd
Department
Type
DUNS #
125250006
City
Georgetown
State
TX
Country
United States
Zip Code
78626
Related projects
NIH 2015
N44 AI
A Multiplexed Diagnostic Immunoassay for Clostridium Difficile and Antibiotic-Associated Diarrhea
Oliver, Kerry / Radix Biosolutions, Ltd
NIH 2015
N44 AI
Inhaled Drug Combination for Tuberculosis Therapy
Carter, Darrick / Pai Life Sciences, Inc.
Comments
Be the first to comment on Kerry Oliver's grant